We Love Entrepreneurs
Venture Garage congratulates Saswat Finance on its $2.6M Pre-Series A raise Gurugram, 18th July 2025: We’re excited to see our portfolio company Saswat Finance mark a key milestone by raising $2.6 million in a Pre-Series A round led by Ankur Capital, with participation from Incubate …
At Rench, we are building an AI-powered infrastructure platform to automate and simplify the treasury, compliance, and wholesale lending workflows of Banks, NBFCs, and financial institutions. Today, there are 100s of software (LOS’, LMS’) to digitise retail lending products. However, the borrowings / treasury of lenders, which is worth $435 bn, 6000+ compliance line items, and entire wholesale lending monitoring across 2.5 cr. borrowers continue to remain highly manual, fragmented, and error-prone.
FinTech | AI | Software/SaasS | Enterprise Tech
www.onrench.com
Gurugram
Early
India has over ₹37 lakh crore ($435 Bn) in borrowing transactions annually, with an additional ₹10 lakh crore ($117 Bn) in payment flows and ₹3 lakh crore ($35 Bn) in investments. The compliance and treasury tech stack is ripe for disruption as financial institutions face increasing complexity, volume, and regulatory scrutiny. We estimate a ₹1,000 Cr ($120 Mn) software revenue opportunity with 80%+ gross margins, targeting 1,500+ large lenders in India and expanding to APAC and GCC regions.
.
Opportunity
Led by a team that has built and exited fintech startups like Paytail, Goldsetu, and Qbera—products that have been adopted by institutions such as ICICI Bank, Standard Chartered, DBS, and InCred.
Co-founder of Paytail, ex-C2FO (ICICI, DBS, Standard Chartered), seasoned in enterprise sales..
Co-founder of Goldsetu, Qbera (acquired by InCred), expert in SaaS GTM and B2B commerce.
Ex- Microsoft, InMobi, Confluent – Tech leader with experience building enterprise-grade AI, big data, and streaming infrastructure across global adtech and fintech platforms
It is India’s first full-stack, tech-enabled care ecosystem dedicated to chronic lower limb health, targeting highly prevalent but underserved conditions like varicose veins, osteoarthritis, diabetic neuropathy, and musculoskeletal degeneration.
The platform uniquely combines biomarker-driven diagnostics, phytotherapy-based treatments, and digitally personalized care pathways—making it a category-defining player in the chronic pain and mobility care space.
Healthtech
www.varcolegcare.com
Gurugram
Growth
TIndia is facing a silent epidemic of chronic pain and mobility disorders:
Varco is addressing this gap with affordable, non-invasive treatments that provide long-term relief through clinically validated phytotherapy, personalized AI care pathways, and blood-based biomarker tracking.
Opportunity
15+ years in scaling B2C healthcare businesses.
PhD in Biochemistry, 20+ years in phyto research, lead inventor on 6 patents
MBBS, MRCEM (UK); architecting scalable hybrid care pathways
